Abstract 3′-O-amino-deoxyribonucleoside triphosphates (3′-ONH2-dNTPs) are crucial reversible terminators for template-independent DNA synthesis. Owing to the structural complexity of purine bases, here we propose a chemo-enzymatic process for the synthesis of purine-type 3′-ONH2-dNTPs. First, the aminoalkoxyl group was introduced into commercially available dA and dG via a chemical catalytic process, affording yields of 24.9% and 27.3%, respectively. Subsequently, to establish a green and scalable enzymatic cascade for phosphorylation of the substrates, we engineered two key phosphorylation enzymes (Dm-dNK and MrPPK2), improving the rate-limiting monophosphorylation of 3′-ONH2-dG from 26% to 97.8% and achieving 59.9% conversion to the corresponding triphosphate. Lastly, the produced nucleotides exhibit performance equivalent to commercial counterparts in terminal deoxynucleotidyl transferase (TdT)-mediated DNA synthesis, supporting the construction of 120-nt strands with ∼99.7% stepwise accuracy. This work establishes an efficient and generalizable catalytic platform for producing modified dNTPs, advancing the practical application of enzymatic DNA synthesis technologies.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: